Fawcett Jan A, Baldessarini Ross J, Coryell William H, Silverman Morton M, Stein Dan J
University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
J Clin Psychiatry. 2009 Oct;70(10):e38. doi: 10.4088/JCP.8145tx1c.
The US Food and Drug Administration warnings that psychotropic medications may increase the risk of suicidality have generated concern about prescribing these agents to patients with psychiatric disorders, many of whom are already at increased risk for suicide. To effectively prevent suicidal behaviors and suicide in clinical practice, clinicians must understand the dangers and benefits associated with psychotropic medications. In addition, they must learn how to identify and manage suicidal risk during treatment.
美国食品药品监督管理局警告称，精神类药物可能会增加自杀倾向风险，这引发了人们对于给患有精神疾病的患者开具此类药物的担忧，而这些患者中的许多人本身就已经面临更高的自杀风险。为了在临床实践中有效预防自杀行为和自杀事件，临床医生必须了解精神类药物相关的风险和益处。此外，他们还必须学会如何在治疗过程中识别和管理自杀风险。
